Current role of perampanel in pediatric epilepsy
Open Access
- 2 June 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Italian Journal of Pediatrics
- Vol. 43 (1), 1-6
- https://doi.org/10.1186/s13052-017-0368-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Pharmacokinetics, exposure–cognition, and exposure–efficacy relationships of perampanel in adolescents with inadequately controlled partial-onset seizuresEpilepsy Research, 2016
- Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies—An Italian observational multicenter studyEpilepsy Research, 2016
- Adjunctive perampanel in adolescents with inadequately controlled partial‐onset seizures: A randomized study evaluating behavior, efficacy, and safetyEpilepsia, 2016
- Update on diagnosis and management of childhood epilepsiesJornal de Pediatria, 2015
- Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanelEpilepsia, 2015
- Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsyEmerging Therapeutic Targets, 2014
- AMPA receptors as a molecular target in epilepsy therapyActa Neurologica Scandinavica, 2013
- Perampanel, a selective, noncompetitive α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial‐onset seizures: Interim results from phase III, extension study 307Epilepsia, 2012
- Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsyEpilepsia, 2011
- Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)Epilepsy Research, 2010